MVX0003 Phase I

Feb 1, 2021 | Clinical Trials

Clinical Trials

Study to Assess a Booster Dose of GBS-NN/NN2 Vaccine

Description:

Assessing the immunogenicity of a single-dose of GBS-NN & GBS-NN2 in vaccine naïve subjects and subjects previously receiving 2 doses of the vaccine as part of MVX002.

Status:

Study has completed enrolment and is ongoing

Countries:

UK

Clinicaltrials.gov